Search Within

CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Amplicons as Vaccine Vectors

Journal: Current Gene Therapy
Volume: 6,Issue: 3
Page: 383-392
Authors: Kathlyn Santos, Cindy M.P. Duke and Stephen Dewhurst

Molecular Pathogenesis of Chronic Lymphocytic Leukemia

Journal: Current Molecular Medicine
Volume: 6,Issue: 6
Page: 665-675
Authors: Alexey V. Danilov, Olga V. Danilova, Andreas K. Klein and Brigitte T. Huber

Genetics, Gene Expression, and Targeted Therapies in Chronic Lymphocytic Leukemia

Journal: Current Drug Targets
Volume: 7,Issue: 10
Page: 1313-1327
Authors: Dirk Winkler, Hartmut Dohner and Stephan Stilgenbauer

Novel Drugs for Chronic Lymphoid Leukemias: Mechanism of Action and Therapeutic Activity

Journal: Current Medicinal Chemistry
Volume: 16,Issue: 18
Page: 2212-2234
Authors: Tadeusz Robak

Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 23
Page: 2652-2664
Authors: Robert J. Kreitman

Wnt/β-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 7
Page: 716-727
Authors: R. K. Gandhirajan, S. J. Poll-Wolbeck, I. Gehrke and K.-A. Kreuzer

Novel Approaches to Modulate Apoptosis Resistance: Basic and Clinical Implications in the Treatment of Chronic Lymphocytic Leukemia (CLL)

Journal: Current Drug Delivery
Volume: 9,Issue: 1
Page: 30-40
Authors: Aisha Masood, Mohammad A. Shahshahan and Ali R. Jazirehi

New and Old Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11,Issue: 6
Page: 508-518
Authors: L. Laurenti, L. De Padua, G. D, ’, Arena, B. Vannata, I. Innocenti, M. Tarnani, S. Deaglio, S. Sica, D. G. Efremov and G. Leone

Synthesis and Biological Activity of New Class of Dioxygenated Anticancer Agents

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 5,Issue: 3
Page: 215-237
Authors: Maria Dolors Pujol, Manel Romero and Isabel Sanchez


Microenvironmental Interactions in Chronic Lymphocytic Leukemia: Hints for Pathogenesis and Identification of Targets for Rational Therapy

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3323-3334
Authors: Michele Dal Bo, Riccardo Bomben, Antonella Zucchetto, Giovanni Del Poeta, Gianluca Gaidano, Silvia Deaglio, Dimitar G. Efremov and Valter Gattei

The Role of B Cell Receptor Stimulation in CLL Pathogenesis

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3335-3355
Authors: Laurens P. Kil, Saravanan Yuvaraj, Anton W. Langerak and Rudi W. Hendriks

Chronic Lymphocytic Leukemia Therapy: Beyond Chemoimmunotherapy

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3356-3362
Authors: Julio Delgado, Tycho Baumann, Gabriela Ghita and Emili Montserrat

Novel Insights in Molecular Mechanisms of CLL

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3363-3372
Authors: Nicola Zanesi, Veronica Balatti, Arianna Bottoni, Carlo M. Croce and Yuri Pekarsky

Immune Dysfunction in Chronic Lymphocytic Leukemia: The Role for Immunotherapy

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3389-3398
Authors: John C. Riches, Alan G. Ramsay and John G. Gribben

Therapy of Elderly/Comorbid Patients with Chronic Lymphocytic Leukemia

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 23
Page: 3399-3405
Authors: Lukas Smolej

Targeting Bcl-2 in CLL

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 30
Page: 5109-5115
Authors: M. Rogalinska and Z.M. Kilianska

Origins and Consequences of AID Expression in Lymphoid Neoplasms

Journal: Current Immunology Reviews
Volume: 9,Issue: 2
Page: 72-85
Authors: Damien Montamat-Sicotte, Florencia Palacios, Javier M. Di Noia and Pablo Oppezzo

MicroRNAs as Main Players in the Pathogenesis of Chronic Lymphocytic Leukemia

Journal: MicroRNA
Volume: 2,Issue: 3
Page: 158-164
Authors: Arianna Bottoni and George A. Calin

Multiple Metamorphoses of CD38 from Prognostic Marker to Disease Modifier to Therapeutic Target in Chronic Lymphocytic Leukemia

Journal: Current Topics in Medicinal Chemistry
Volume: 13,Issue: 23
Page: 2955-2964
Authors: Tiziana Vaisitti, Valentina Audrito, Sara Serra, Cinzia Bologna, Francesca Arruga, Davide Brusa, Roberta Buonincontri, Branimir Gizdic and Silvia Deaglio

Chrysin Induces Apoptosis in Peripheral Blood Lymphocytes Isolated from Human Chronic Lymphocytic Leukemia

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 2
Page: 189-195
Authors: Milan Zaric, Marina Mitrovic, Ivana Nikolic, Dejan Baskic, Suzana Popovic, Predrag Djurdjevic, Zoran Milosavljevic and Ivanka Zelen

AKT-pathway Inhibition in Chronic Lymphocytic Leukemia Reveals Response Relationships Defined by TCL1

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 8
Page: 700-712
Authors: Alexandra Schrader, Wagma Popal, Nils Lilienthal, Giuliano Crispatzu, Petra Mayer, Dan Jones, Michael Hallek and Marco Herling

Cell Penetrating Peptides as a Therapeutic Strategy in Chronic Lymphocytic Leukemia

Journal: Protein & Peptide Letters
Volume: 22,Issue: 6
Page: 539-546
Authors: Issam Arrouss, Didier Decaudin, Sylvain Choquet, Nabih Azar, Christophe Parizot, Jean M. Zini, Fariba Nemati and Angelita Rebollo

Targeting Signaling Pathways in Chronic Lymphocytic Leukemia

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 8
Page: 669-688
Authors: Alice F. Muggen, Simar P. Singh, Rudi W. Hendriks and Anton W. Langerak

Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 8
Page: 710-720
Authors: Lukas Smolej

Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 8
Page: 701-709
Authors: Lukas Smolej

Deregulation of Apoptosis - Is it Still an Important Issue in Pathogenesis of Chronic Lymphocytic Leukemia?

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 8
Page: 652-658
Authors: Monika Podhorecka, Arkadiusz Macheta, Maria Bozko, Andrzej Bozko, Nisar P. Malek and Przemyslaw Bozko

Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 8
Page: 659-668
Authors: Michele Dal Bo, Erika Tissino, Dania Benedetti, Chiara Caldana, Riccardo Bomben, Giovanni Del Poeta, Gianluca Gaidano, Francesca Maria Rossi, Pietro Bulian, Antonella Zucchetto and Valter Gattei

MicroRNAs in Chronic Lymphocytic Leukemia: An Old Disease with New Genetic Insights

Journal: MicroRNA
Volume: 5,Issue: 2
Page: 106-112
Authors: Maria Ciccone and George A. Calin

Survival and Immunosuppression Induced by Hepatocyte Growth Factor in Chronic Lymphocytic Leukemia

Journal: Current Molecular Medicine
Volume: 17,Issue: 1
Page: 24-33
Authors: P. Giannoni, G. Cutrona and D. de Totero*

Pentoxifylline-Induced Apoptosis in Chronic Lymphocytic Leukemia: New Insights into Molecular Mechanism

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 18,Issue: 3
Page: 287-294
Authors: Roberta Napolitano, Serena De Matteis, Alessandro Lucchesi, Silvia Carloni*, Delia Cangini, Gerardo Musuraca, Eliana Valentina Liardo, Marianna Norata and Pier Paolo Fattori

Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 18,Issue:
Page: 1-28
Authors: Ota Fuchs*